PELI1 Protein

PELI1 Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">PELI1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Pellino E3 Ubiquitin Protein Ligase 1</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>[PELI1](/genes/pellino1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q8WXX3](https://www.uniprot.org/uniprot/Q8WXX3)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~47 kDa</td></tr>
<tr><td><strong>Length</strong></td><td>420 amino acids</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Pellino family (E3 ubiquitin ligases)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Cytoplasm, Nucleus</td></tr>
</table>
</div>

Overview

PELI1 (Pellino E3 Ubiquitin Protein Ligase 1) is a 420-amino acid E3 ubiquitin ligase that plays critical roles in innate immunity, inflammatory signaling, and neurological function. As a member of the Pellino family of RING-type E3 ubiquitin ligases, PELI1 catalyzes the transfer of ubiquitin to target proteins, thereby regulating signaling pathways that control cytokine production, microglial activation, and synaptic plasticity [1](https://pubmed.ncbi.nlm.nih.gov/21796149/).

PELI1 Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">PELI1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Pellino E3 Ubiquitin Protein Ligase 1</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>[PELI1](/genes/pellino1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q8WXX3](https://www.uniprot.org/uniprot/Q8WXX3)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~47 kDa</td></tr>
<tr><td><strong>Length</strong></td><td>420 amino acids</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Pellino family (E3 ubiquitin ligases)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Cytoplasm, Nucleus</td></tr>
</table>
</div>

Overview

PELI1 (Pellino E3 Ubiquitin Protein Ligase 1) is a 420-amino acid E3 ubiquitin ligase that plays critical roles in innate immunity, inflammatory signaling, and neurological function. As a member of the Pellino family of RING-type E3 ubiquitin ligases, PELI1 catalyzes the transfer of ubiquitin to target proteins, thereby regulating signaling pathways that control cytokine production, microglial activation, and synaptic plasticity [1](https://pubmed.ncbi.nlm.nih.gov/21796149/).

PELI1 has emerged as an important player in neurodegenerative diseases through its regulation of [NF-κB](/mechanisms/nf-kb-signaling) signaling and [neuroinflammation](/mechanisms/neuroinflammation). Genetic variants in PELI1 have been associated with increased susceptibility to multiple sclerosis (MS), and altered PELI1 expression has been documented in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions [2](https://pubmed.ncbi.nlm.nih.gov/30658742/). The protein's dual roles in immune regulation and neuronal function position it at the intersection of neuroinflammation and neurodegeneration.

Structure and Domain Architecture

PELI1 is a modular protein containing several functional domains that enable its E3 ubiquitin ligase activity and protein-protein interactions:

RING Domain

The C-terminal RING (Really Interesting New Gene) finger domain is the hallmark of E3 ubiquitin ligases. This domain coordinates zinc ions through conserved cysteine and histidine residues, forming a compact structure that catalyzes ubiquitin transfer from E2 conjugating enzymes to substrate proteins [3](https://pubmed.ncbi.nlm.nih.gov/12668763/). The RING domain of PELI1 (spanning residues 350-410) mediates interactions with E2 enzymes including UBC13/UEV1A, which are required for K63-linked polyubiquitin chain synthesis.

Pellino Homology Region

Adjacent to the RING domain, the Pellino homology region (PHR) spans approximately 100 residues and is unique to Pellino family proteins. This region participates in protein-protein interactions and contributes to substrate recognition. The PHR domain can bind to phosphorylated Toll/IL-1 receptor domain-containing adaptor proteins, positioning PELI1 to regulate Toll-like receptor (TLR) signaling [4](https://pubmed.ncbi.nlm.nih.gov/15994408/).

N-Terminal Domain

The N-terminal region of PELI1 contains additional regulatory elements that control ligase activity. This region can undergo conformational changes that modulate interactions with upstream kinases and downstream substrates. Post-translational modifications including phosphorylation and ubiquitination within this domain regulate PELI1 activity in response to cellular signals.

Biological Functions

Regulation of NF-κB Signaling

PELI1 is a key regulator of the NF-κB signaling pathway, one of the master regulators of inflammatory gene expression. PELI1 catalyzes K63-linked ubiquitination of key signaling intermediates, including TRAF6 and TAK1, which are essential for NF-κB activation downstream of Toll-like receptors and IL-1 receptors [5](https://pubmed.ncbi.nlm.nih.gov/15601823/).

The regulation of NF-κB by PELI1 operates through several mechanisms:

TRAF6 Ubiquitination: PELI1 ubiquitinates TRAF6, enabling its signaling function in the NF-κB cascade. This modification is critical for TLR-mediated inflammatory gene activation.

TAK1 Activation: PELI1 contributes to TAK1 (TGF-beta-activated kinase 1) activation through K63-linked ubiquitination, creating a positive feedback loop that amplifies NF-κB signaling.

IκB Kinase (IKK) Activation: The PELI1-TRAF6-TAK1 axis ultimately leads to IKK activation, which phosphorylates IκBα and triggers NF-κB nuclear translocation.

TLR Signaling and Innate Immunity

PELI1 plays essential roles in innate immune signaling downstream of Toll-like receptors. Upon pathogen-associated molecular pattern (PAMP) recognition, TLRs recruit adaptor proteins including MyD88 and TRAF6, creating a signaling platform where PELI1 participates in ubiquitination reactions that drive inflammatory cytokine production [6](https://pubmed.ncbi.nlm.nih.gov/19158678/).

Key TLR-regulated functions of PELI1 include:

• Production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6)
• Type I interferon induction in response to viral infection
• Regulation of chemokine expression for immune cell recruitment

Microglial Activation

In the central nervous system, PELI1 is highly expressed in microglia, the resident immune cells of the brain. PELI1 regulates microglial activation states and inflammatory responses, influencing the neuroinflammatory processes that contribute to neurodegeneration [7](https://pubmed.ncbi.nlm.nih.gov/29154876/).

Microglial PELI1 functions include:

• Modulation of pro-inflammatory cytokine production
• Regulation of phagocytic activity
• Control of reactive oxygen species generation
• Influence on microglial morphologic changes

Synaptic Plasticity and Learning

Beyond its immune functions, PELI1 is expressed in neurons where it participates in synaptic plasticity. Studies have demonstrated that PELI1 localizes to synaptic compartments and regulates postsynaptic signaling cascades involved in learning and memory formation [8](https://pubmed.ncbi.nlm.nih.gov/26231742/).

Neuronal PELI1 functions include:

• Modulation of AMPA receptor trafficking
• Regulation of dendritic spine morphology
• Influence on long-term potentiation (LTP)
• Effects on memory consolidation

Role in Neurodegenerative Diseases

Multiple Sclerosis

PELI1 genetic variants have been strongly associated with multiple sclerosis susceptibility. Genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) in the PELI1 gene region that increase MS risk, likely through effects on immune regulation [9](https://pubmed.ncbi.nlm.nih.gov/21796149/).

The mechanisms by which PELI1 contributes to MS pathogenesis include:

Altered Immune Regulation: PELI1 variants may dysregulate TLR signaling in immune cells, leading to exaggerated inflammatory responses against myelin antigens.

Microglial Activation: Enhanced PELI1 activity in microglia may promote pro-inflammatory activation, driving demyelination and axonal loss.

T Cell Function: PELI1 influences T cell activation and polarization, potentially affecting the autoimmune response in MS.

Alzheimer's Disease

PELI1 expression and function are altered in Alzheimer's disease brains, where it contributes to the neuroinflammatory environment that characterizes AD pathology [10](https://pubmed.ncbi.nlm.nih.gov/30658742/).

In Alzheimer's disease:

Microglial Neuroinflammation: PELI1 promotes pro-inflammatory cytokine production in microglia surrounding amyloid plaques, creating a chronic inflammatory milieu that accelerates neuronal loss.

Tau Pathology: Evidence suggests PELI1 may interact with tau phosphorylation pathways, potentially influencing the spread of tau pathology.

Synaptic Dysfunction: Altered neuronal PELI1 expression may contribute to synaptic deficits in AD through effects on receptor trafficking and plasticity mechanisms.

Parkinson's Disease

In Parkinson's disease, PELI1 contributes to neuroinflammation through its regulation of microglial activation. Studies have detected altered PELI1 expression in the substantia nigra of PD brains, with elevated levels in activated microglia [11](https://pubmed.ncbi.nlm.nih.gov/25893312/).

PELI1 functions in PD include:

• Regulation of dopaminergic neuron vulnerability to inflammatory stress
• Modulation of microglial phagocytosis of neuronal debris
• Influence on neuroinflammation-driven progression

Amyotrophic Lateral Sclerosis

PELI1 has been implicated in amyotrophic lateral sclerosis (ALS) through its roles in neuroinflammation and protein quality control. The protein may influence the aggregation of TDP-43 and SOD1 proteins that characterize ALS pathology [12](https://pubmed.ncbi.nlm.nih.gov/27793229/).

Stroke and Brain Injury

PELI1 contributes to the inflammatory response following stroke and traumatic brain injury. The protein is upregulated in response to ischemia and modulates both protective and harmful inflammatory processes [13](https://pubmed.ncbi.nlm.nih.gov/28951456/).

Therapeutic Targeting

The central role of PELI1 in neuroinflammation makes it an attractive therapeutic target for neurodegenerative diseases:

Small Molecule Inhibitors

Developing PELI1 inhibitors faces challenges due to the difficulty of targeting protein-protein interactions required for E3 ligase function. Nevertheless, screening efforts have identified compounds that can modulate PELI1 activity.

Modulation of Upstream Pathways

Rather than targeting PELI1 directly, therapeutic strategies may modulate upstream activators (TLR ligands, cytokine receptors) or downstream effectors (NF-κB, inflammatory cytokines).

Microglial Modulation

Approaches that shift microglial polarization from pro-inflammatory (M1) to anti-inflammatory (M2) states may bypass the need for direct PELI1 inhibition while achieving similar anti-inflammatory effects.

Interaction Network

PELI1 interacts with numerous proteins relevant to neurodegeneration:

• TRAF6: Primary ubiquitination target in NF-κB signaling
• TAK1: Kinase in NF-κB activation cascade
• MyD88: TLR adaptor protein
• IRAK1/4: kinases in TLR signaling
• NF-κB subunits: Downstream transcription factors
• TLRs: Pattern recognition receptors
• Synaptic proteins: PSD-95, AMPA receptor subunits

Summary

PELI1 is an E3 ubiquitin ligase with critical roles in innate immunity, neuroinflammation, and synaptic function. Its genetic association with multiple sclerosis susceptibility and documented alterations in Alzheimer's and Parkinson's diseases highlight its importance in neurodegeneration. Through its regulation of NF-κB signaling and microglial activation, PELI1 influences the neuroinflammatory processes that contribute to neuronal dysfunction and death. Understanding PELI1 biology may reveal therapeutic opportunities for modulating neuroinflammation in neurodegenerative diseases.

See Also

• [PELI1 Gene](/genes/pellino1)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [NF-κB Signaling](/mechanisms/nf-kb-signaling)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Microglia](/cell-types/microglia)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)

External Links

• [UniProt: PELI1](https://www.uniprot.org/uniprot/Q8WXX3)
• [NCBI Gene: PELI1](https://www.ncbi.nlm.nih.gov/gene/57162)
• [PDB: PELI1 Structure](https://www.rcsb.org/)

References